Home > Insider Trading > Filing (0000899243-23-012433)

Filing Details

Accession Number:: 0000899243-23-012433
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-05-08 21:15:01
Reporting Period:: 2023-03-24

Accepted Time:: 2023-05-08 21:15:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
730272	Repligen Corp	RGEN	Biological Products, (No Disgnostic Substances) (2836)	042729386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1310268	D Martin Madaus	C/O Repligen Corporation 41 Seyon St., Bldg 1, Ste 100 Waltham MA 02453		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-03-24	11	$186.22	11	No	4	L	Indirect	See Footnote
Common Stock	Acquisiton	2023-05-04	500	$161.15	611	No	4	P	Direct
Common Stock	Acquisiton	2023-05-05	500	$159.19	1,111	No	4	P	Direct
Common Stock	Acquisiton	2023-05-08	500	$156.18	1,611	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	L	Indirect	See Footnote
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

$186.22 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $160.14 to $218.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
$161.15 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $160.85 to $161.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
$159.19 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $158.96 to $159.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
$156.18 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $156.10 to $156.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
Shares held by a revocable trust of which the Reporting Person's spouse serves as trustee. Such shares were unintentionally omitted from the Form 3 originally filed by the Reporting Person on February 8, 2023, and were also omitted from a Form 4 subsequently filed by the Reporting Person on the same date. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.